Effects of appendectomy and oral tolerance on dextran sulfate sodium colitis

World Journal of Gastroenterology

Volumn 17, Issue 19, 2011, Pages 2437-2445

  Yue, Min ^a   Shen, Zhe ^a   Yu, Chao Hui ^a   Ye, Hua ^a   Ye, Yue Fang ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Appendicectomy; Dextrin sulfate sodium; Murine colitis; Oral tolerance; Th1 Th2 balance

Indexed keywords

COLON EXTRACTED PROTEIN; DEXTRAN SULFATE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APPENDECTOMY; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PROTECTION; SPLEEN LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 79957853811     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i19.2437     Document Type: Article

References (37)

1. Vatn MH. Natural history and complications of IBD. Curr Gastroenterol Rep 2009; 11: 481-487
2. Wang J, Toes RE. Mechanisms of oral tolerance revisited. Arthritis Res Ther 2008; 10: 108
3. Sonier B, Patrick C, Ajjikuttira P, Scott FW. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. Int Rev Immunol 2009; 28: 414-445
4. Blumberg RS. Inflammation in the intestinal tract: pathogenesis and treatment. Dig Dis 2009; 27: 455-464
5. Hyun JG, Barrett TA. Oral tolerance therapy in inflammatory bowel disease. Am J Gastroenterol 2006; 101: 569-571
6. Judge T, Lichtenstein GR. Is the appendix a vestigial organ? Its role in ulcerative colitis. Gastroenterology 2001; 121: 730-732
7. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med 1996; 184: 707-715
8. Korzenik JR. Is Crohn's disease due to defective immunity? Gut 2007; 56: 2-5
9. Eckmann L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann N Y Acad Sci 2006; 1072: 28-38
10. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251-1253
11. Eaton AD, Xu D, Garside P. Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology 2003; 108: 196-203
12. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702
13. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Peña AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114: 385-391
14. Dasgupta A, Kesari KV, Ramaswamy KK, Amenta PS, Das KM. Oral administration of unmodified colonic but not small intestinal antigens protects rats from hapten-induced colitis. Clin Exp Immunol 2001; 125: 41-47
15. López MC, Márquez MG, Slobodianik NH, Roux ME. Oral tolerance to dextrin mediated by specific suppressor T-cells induced in the intestinal intraepithelium and their systemic migration. Lymphology 2003; 36: 26-38
16. Braus NA, Elliott DE. Advances in the pathogenesis and treatment of IBD. Clin Immunol 2009; 132: 1-9
17. Bolin TD, Wong S, Crouch R, Engelman JL, Riordan SM. Appendicectomy as a therapy for ulcerative proctitis. Am J Gastroenterol 2009; 104: 2476-2482
18. Timmer A, Obermeier F. Reduced risk of ulcerative colitis after appendicectomy. BMJ 2009; 338: b225
19. Florin TH, Pandeya N, Radford-Smith GL. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Gut 2004; 53: 973-979
20. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000; 95: 171-176
21. Okazaki K, Onodera H, Watanabe N, Nakase H, Uose S, Matsushita M, Kawanami C, Imamura M, Chiba T. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 2000; 119: 502-506
22. Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Järnerot G. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006; 12: 925-933
23. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183: 2605-2616
24. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 1996; 157: 2174-2185
25. Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Chowdhury NR, Chowdhury JR, Goldin E. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Am J Gastroenterol 2000; 95: 966-973
26. Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004; 126: 1771-1778
27. Margalit M, Israeli E, Shibolet O, Zigmond E, Klein A, Hemed N, Donegan JJ, Rabbani E, Goldin E, Ilan Y. A doubleblind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colonextracted proteins: a patient-tailored approach. Am J Gastroenterol 2006; 101: 561-568
28. Dasgupta A, Ramaswamy K, Giraldo J, Taniguchi M, Amenta PS, Das KM. Colon epithelial cellular protein induces oral tolerance in the experimental model of colitis by trinitrobenzene sulfonic acid. J Lab Clin Med 2001; 138: 257-269
29. Gotsman I, Shlomai A, Alper R, Rabbani E, Engelhardt D, Ilan Y. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. J Pharmacol Exp Ther 2001; 297: 926-932
30. Nakase H, Mikami S, Chiba T. Alteration of CXCR4 expression and Th1/Th2 balance of peripheral CD4-positive T cells can be a biomarker for leukocytapheresis therapy for patients with refractory ulcerative colitis. Inflamm Bowel Dis 2009; 15: 963-964
31. Dohi T, Fujihashi K, Koga T, Shirai Y, Kawamura YI, Ejima C, Kato R, Saitoh K, McGhee JR. T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology 2003; 124: 672-682
32. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, Mc- Ghee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189: 1169-1180
33. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296: 490-494
34. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34: 2690-2698
35. Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, Weinstock JV. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 2003; 284: G385-G391
36. Mähler M, Bristol IJ, Sundberg JP, Churchill GA, Birkenmeier EH, Elson CO, Leiter EH. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 1999; 55: 147-156
37. Ueno Y, Tanaka S, Sumii M, Miyake S, Tazuma S, Taniguchi M, Yamamura T, Chayama K. Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice. Inflamm Bowel Dis 2005; 11: 35-41